Experts have raised concerns that this strain can dodge existing immunity and can spread from human to human rapidly ...

The FDA will make it more costly to seek approval of Covid-19 vaccines, but Moderna's shareholder reacted favorable to the ...

Amidst rising COVID-19 cases in Asia, Yale University researchers have discovered that nasal vaccine boosters offer a safer ...

Changes are on the way for COVID vaccines after the FDA adjusted the standard of evidence needed to approve shots for the general public.

World Health Organization member countries on Tuesday approved an agreement to better prevent, prepare for and respond to ...

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk ...

Healthy adults younger than 65 will no longer be eligible for COVID-19 shots starting in the fall, according to new federal guidelines announced Tuesday.

Dr. Susan Girois hosted the conversation discussing several topics relating to vaccines, including how they are developed and tested.

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults ...

Dr. Peter Chin Hong, a Bay Area infectious disease expert, discusses the stricter policy from the Food and Drug ...